Longeveron Inc. Profile Avatar - Palmy Investing

Longeveron Inc.

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture…

Biotechnology
US, Miami [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Longeveron Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Longeveron Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Longeveron Inc..

End of LGVN's Analysis
CIK: 1721484 CUSIP: 54303L104 ISIN: US54303L1044 LEI: - UEI: -
Secondary Listings
LGVN has no secondary listings inside our databases.